Adverum Biotechnologies, Inc.

符号: ADVM

NASDAQ

10.43

USD

今天的市场价格

-0.9010
市盈率
0.0140
PEG比率
216.49M
MRK市值
0.00%
DIV收益率

Adverum Biotechnologies, Inc. (ADVM) 财务报表

Q: 什么是 Adverum Biotechnologies, Inc. (ADVM) 总资产是多少？

Adverum Biotechnologies, Inc. (ADVM) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Adverum Biotechnologies, Inc. (ADVM). 的默认数据。公司收入显示 1.639 M 的平均值，即 1.264 % 增长率。整个期间的平均毛利润为 -0.109 M，即 -0.115 %. 平均毛利率为 0.651 %. 公司去年的净收入增长率为 -0.242 %，等于 -0.712 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Adverum Biotechnologies, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.439. 在流动资产领域，ADVM 的报告货币为102.773. 这些资产中的很大一部分，即 96.526 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.480%. 公司的长期投资虽然不是其重点，但以报告货币计算的1.976（如果有的话）为1.976。这表明与上一报告期相比，-21.055% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 64.627. 这一数字表明，-0.297% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 83.469. 这方面的年同比变化率为 -0.540%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为0，存货估值为 0，商誉估值为 0（如有. 无形资产总额（如果有）按 0 估值. 应付账款和短期债务分别为 1.92 和 10.41. 债务总额为75.04，债务净额为 0.04. 其他流动负债为 12.48，加上总负债 89.54. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
balance-sheet.row.cash-and-short-term-investments	519.35	96.5	185.6	305.2	429.7	166	205.1	190.5	222.2	259.1	159.4	0.6	0.4
balance-sheet.row.short-term-investments	160.24	21.5	117.2	271	367.3	100.1	50.1	120	0	37.7	0	0	0
balance-sheet.row.net-receivables	0	0	0	5.7	0	0	0	0	0.9	0.4	0	0	0
balance-sheet.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	24.04	6.2	5	6.2	4.7	9.8	3.7	3.3	2.2	1.5	0.9	0.3	0
balance-sheet.row.total-current-assets	543.38	102.8	190.6	317.1	434.4	175.9	208.8	193.7	225.3	261	160.3	0.8	0.4
balance-sheet.row.property-plant-equipment-net	328.46	67	113.9	119.1	47.1	45.8	3.6	3	4.2	3.2	1.1	0.1	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	5	5	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	5	5	0	0	0	0
balance-sheet.row.long-term-investments	9.78	2	2.5	3.3	1	1	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	5.16	1.2	1.4	0.3	0	0	1.2	0.1	0.1	0.1	0.5	0.2	0
balance-sheet.row.total-non-current-assets	343.4	70.2	117.8	122.6	48.1	46.9	4.7	8.2	9.3	3.3	1.6	0.3	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	886.79	173	308.4	439.7	482.6	222.7	213.5	201.9	234.6	264.3	161.9	1.1	0.4
balance-sheet.row.account-payables	8.37	1.9	2.2	1.4	2.8	4.1	1.7	1.7	1.5	0.6	1	0.8	0.5
balance-sheet.row.short-term-debt	72.39	10.4	13.2	1.9	4.5	4	0	6.8	6.5	4.1	3.7	0	0
balance-sheet.row.tax-payables	0.54	0.1	0.3	1.3	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	266.93	64.6	93.6	101.1	26.2	28.2	0	0.2	0.4	0	0	0	0.5
Deferred Revenue Non Current	0	0	0	0	0	0	0	5.3	7.1	4.7	6.6	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	33.49	12.5	16.8	2	1.3	2.6	9	0.2	0	1	0	0.4	0.3
balance-sheet.row.total-non-current-liabilities	266.93	64.6	94.6	102.2	27.3	28.4	1.6	7.2	9.1	5.2	7	0.1	0.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	328.92	64.6	106.8	103	30.7	32.2	0	0	0	0	0	0	0
balance-sheet.row.total-liab	411.69	89.5	126.9	123.5	48.2	47.8	12.3	17.9	19	11.7	12.4	1.3	1.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	161.9	8	2.5
balance-sheet.row.common-stock	0.04	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-3510.69	-919.8	-802.6	-648.1	-502.5	-385	-320.5	-254.1	-197.9	-84.2	-36.7	-8.9	-3.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	-2.43	-0.5	-1.5	-0.7	-0.3	-0.7	-0.8	-1	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3988.17	1003.7	985.7	965	937.1	560.7	522.5	439	413.5	336.8	24.3	0.6	0.1
balance-sheet.row.total-stockholders-equity	475.1	83.5	181.5	316.2	434.3	175	201.2	184	215.6	252.6	149.5	-0.2	-1
balance-sheet.row.total-liabilities-and-stockholders-equity	886.79	173	308.4	439.7	482.6	222.7	213.5	201.9	234.6	264.3	161.9	1.1	0.4
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	475.1	83.5	181.5	316.2	434.3	175	201.2	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	886.79	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	162.22	23.5	117.2	271	367.3	100.1	50.1	120	0	37.7	0	0	0
balance-sheet.row.total-debt	339.32	75	106.8	103	30.7	32.2	0	0	0	0	0	0	0.5
balance-sheet.row.net-debt	-19.78	0	38.4	68.8	-31.7	-33.6	-154.9	-70.5	-222.2	-259.1	-159.4	-0.6	0.1

现金流量表

在 Adverum Biotechnologies, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.232 的转变。该公司最近通过发行 0.49 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到96875000.000. 与上一年相比， -0.316 发生了变化. 在同一时期，公司记录了 5.64, 0 和 0，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -0.42，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
cash-flows.row.net-income	-117.17	-117.2	-154.5	-145.5	-117.5	-64.5	-72.6	-56.1	-113.7	-47.5	-25.4	-5.3	-1.8
cash-flows.row.depreciation-and-amortization	5.64	5.6	6.5	4.6	4.2	1.6	1.8	2.1	1.6	0.8	0.2	0	0
cash-flows.row.deferred-income-tax	-7.26	0.4	0	3.8	0.9	-1.3	-1.3	0.6	60.7	0.8	1	1.7	0
cash-flows.row.stock-based-compensation	17.57	17.6	20.1	25.2	20.4	9.9	13.4	8.7	11.4	11.5	8.6	0.5	0.1
cash-flows.row.change-in-working-capital	-8.32	-8.3	19.9	4.1	12.7	5.1	-1.6	-0.8	1.6	-1.2	10	-0.1	0.5
cash-flows.row.account-receivables	0	0	0	0	0	0	0	0.9	-0.4	0	0	0	0
cash-flows.row.inventory	0	0	0	0	0	0	0	0	-1.1	1.2	2.3	-0.4	0
cash-flows.row.account-payables	-0.37	-0.4	0.8	-1.6	1.6	-0.7	-0.1	0.3	-0.1	-0.3	0	0.3	0.4
cash-flows.row.other-working-capital	-7.95	-7.9	19	5.7	11.1	5.7	-1.6	-1.9	3.3	-2.1	7.8	0	0
cash-flows.row.other-non-cash-items	18.55	10.6	-0.1	0	0.1	0.1	6.4	0.1	0	0.2	0	0.9	0
cash-flows.row.net-cash-provided-by-operating-activities	-90.98	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.81	-0.8	-11.8	-15.1	-11.8	-19.2	-0.8	-1	-2.4	-3	-0.9	-0.1	0
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	3.4	0	0	0	0
cash-flows.row.purchases-of-investments	-36.72	-36.7	-104.4	-407.5	-570.4	-197.3	-78.7	-209.8	-38.8	-88.4	0	0	0
cash-flows.row.sales-maturities-of-investments	134.4	134.4	257.9	501.3	302.1	148.5	149	88.6	37.7	49.9	0	0	0
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0	0	38.8	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	96.88	96.9	141.7	78.7	-280.2	-68.1	69.4	-122.2	38.8	-41.6	-0.9	-0.1	0
cash-flows.row.debt-repayment	-2.34	0	-13.6	-0.2	-0.1	-0.1	-0.2	0	0	0	0	0	0
cash-flows.row.common-stock-issued	0.49	0.5	0	1.7	344.3	25.9	70.2	16.5	0	139	116.5	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	-4	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	1.06	-0.4	14.2	1	11.7	2.4	-0.1	0.2	0.6	-0.1	53	2.5	0.5
cash-flows.row.net-cash-used-provided-by-financing-activities	-0.72	0.5	0.6	2.4	356	28.2	69.9	16.7	0.6	138.9	165.4	2.5	0.5
cash-flows.row.effect-of-forex-changes-on-cash	1.54	0.5	0	0	0	0	0	-0.8	-0.1	0	0	0	0
cash-flows.row.net-change-in-cash	6.72	6.6	34.2	-26.7	-3.5	-89.1	85.4	-151.7	0.8	61.9	158.8	0.2	-0.8
cash-flows.row.cash-at-end-of-period	366.91	75	70.9	36.7	63.4	66.9	155.9	70.5	222.2	221.3	159.4	0.6	0.4
cash-flows.row.cash-at-beginning-of-period	360.19	68.4	36.7	63.4	66.9	155.9	70.5	222.2	221.3	159.4	0.6	0.4	1.1
cash-flows.row.operating-cash-flow	-90.98	-91.3	-108.1	-107.8	-79.3	-49.2	-54	-45.4	-38.4	-35.3	-5.6	-2.2	-1.3
cash-flows.row.capital-expenditure	-0.81	-0.8	-11.8	-15.1	-11.8	-19.2	-0.8	-1	-2.4	-3	-0.9	-0.1	0
cash-flows.row.free-cash-flow	-91.79	-92.1	-119.9	-123	-91.1	-68.4	-54.8	-46.4	-40.8	-38.3	-6.6	-2.3	-1.3

利润表行

Adverum Biotechnologies, Inc. 的收入与上期相比变化了 0.000%。据报告, ADVM 的毛利润为 -2.04。该公司的营业费用为 121.75，与上年相比变化了 -22.521%. 折旧和摊销费用为 5.64，与上一会计期间相比变化了 -0.135%. 营业费用报告为 121.75，显示-22.521% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.212%. 营业收入为 -123.79，与上年相比变化了-0.212%. 净利润的变化率为 -0.242%。去年的净收入为-117.17.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
income-statement-row.row.total-revenue	3.6	3.6	0	7.5	0	0.3	1.6	1.8	1.5	2.3	0.6	0.5	0
income-statement-row.row.cost-of-revenue	12.58	5.6	6.5	4.6	4.2	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	-8.98	-2	-6.5	2.9	-4.2	0.3	1.6	1.8	1.5	2.3	0.6	0.5	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	77.48	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	49.91	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-1.01	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5.75	5.7	2.7	0.6	1.6	4.1	4.2	2.7	0.8	0.4	-1	-0.1	0
income-statement-row.row.operating-expenses	126.38	121.7	157.1	153.6	118	68.8	74.7	60.7	56	47.6	25	3.5	1.8
income-statement-row.row.cost-and-expenses	127.39	127.4	157.1	153.6	118	68.8	74.7	60.7	56	47.6	25	3.5	1.8
income-statement-row.row.interest-income	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	-1.2	0	-2.7	0	0	0	0	0	0	0	0	0.1	0
income-statement-row.row.selling-and-marketing-expenses	-1.01	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	5.55	5.5	2.7	0.6	1.6	4.1	-0.8	2.7	-60	-2.2	-1	-1.7	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5.75	5.7	2.7	0.6	1.6	4.1	4.2	2.7	0.8	0.4	-1	-0.1	0
income-statement-row.row.total-operating-expenses	5.55	5.5	2.7	0.6	1.6	4.1	-0.8	2.7	-60	-2.2	-1	-1.7	0
income-statement-row.row.interest-expense	-1.2	0	-2.7	0	0	0	0	0	0	0	0	0.1	0
income-statement-row.row.depreciation-and-amortization	5.64	5.6	6.5	4.6	4.2	1.6	1.8	2.1	1.6	0.8	0.2	0	0
income-statement-row.row.ebitda-caps	-118.15	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-123.79	-123.8	-157.1	-146.1	-118	-68.5	-78.1	-58.8	-115.3	-47.8	-24.4	-3.5	-1.8
income-statement-row.row.income-before-tax	-118.24	-118.2	-154.5	-145.5	-116.4	-64.5	-73.9	-56.1	-114.5	-47.5	-25.4	-5.3	-1.8
income-statement-row.row.income-tax-expense	-1.08	-1.1	0.1	0	1.1	0	-1.3	0	-0.8	1.8	-0.2	0	0
income-statement-row.row.net-income	-117.17	-117.2	-154.5	-145.5	-117.5	-64.5	-72.6	-56.1	-113.7	-47.5	-25.4	-5.3	-1.8